drugset / Trial / NCT02789475

DP-R212 Pharmacokinetic Study

NCT02789475

Phase 1 Unknown 38 enrolled Alvogen Korea
Non-randomizedParallel-groupOpen-labelTreatment

Summary

An open-label, multiple-dose study to evaluate the pharmacokinetic drug-drug interaction of amlodipine and rosuvastatin in healthy adult male subjects.

Timeline

Start
2016-05
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Rosuvastatin Small molecule